Metraipolis › archive › dc_4ff3e29ea315
EZH2 in Acral Lentiginous Melanoma: Molecular, Epigenetic, and Therapeutic Perspectives — Europe PMC PMID:42220432
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42220432
- DOI
- 10.32604/or.2026.077913
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T09:29:36.341Z
- SHA-256 of the archived text
235fcf1942309a8b054f4ed97fb8b57195d53f6a367b2af4bfe42294c5c3a0b1- Stable URL of this page
https://metraipolis.com/documento/dc_4ff3e29ea315
How to cite
EZH2 in Acral Lentiginous Melanoma: Molecular, Epigenetic, and Therapeutic Perspectives — Europe PMC PMID:42220432 — Europe PMC (en), https://europepmc.org/article/MED/42220432 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4ff3e29ea315 (Metraipolis archive dc_4ff3e29ea315, sha256 235fcf1942309a8b054f4ed97fb8b57195d53f6a367b2af4bfe42294c5c3a0b1)
BibTeX
@misc{dc4ff3e29ea315,
title = {EZH2 in Acral Lentiginous Melanoma: Molecular, Epigenetic, and Therapeutic Perspectives — Europe PMC PMID:42220432},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42220432},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4ff3e29ea315; sha256 235fcf1942309a8b054f4ed97fb8b57195d53f6a367b2af4bfe42294c5c3a0b1},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42220432. Agents can read the archived copy with the MCP tool read_document.